Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122455) titled 'A real-world cohort study of the entire growth and development cycle of children: analysis of the long-term safety and key factors of rhGH based on a multicenter long-term follow-up database' on April 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
Condition:
Growth retardation
Intervention:
GH treatment group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: GH treatment group:11500;Non-GH treatment group:23500;
Countries of Recruitment...